IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.983
EU - Europa 1.499
AS - Asia 1.223
SA - Sud America 228
AF - Africa 43
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.947
CN - Cina 439
SG - Singapore 374
IT - Italia 327
IE - Irlanda 295
SE - Svezia 226
BR - Brasile 202
HK - Hong Kong 172
DE - Germania 154
FI - Finlandia 151
TR - Turchia 108
NL - Olanda 83
AT - Austria 49
RU - Federazione Russa 41
GB - Regno Unito 39
FR - Francia 30
IN - India 30
CI - Costa d'Avorio 28
BE - Belgio 24
CZ - Repubblica Ceca 19
CA - Canada 17
KR - Corea 17
ID - Indonesia 15
VN - Vietnam 15
LU - Lussemburgo 12
ES - Italia 11
AR - Argentina 10
MX - Messico 10
PK - Pakistan 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
UA - Ucraina 6
ZA - Sudafrica 6
CO - Colombia 5
IQ - Iraq 5
LT - Lituania 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
EG - Egitto 4
JP - Giappone 4
AU - Australia 3
BD - Bangladesh 3
BO - Bolivia 3
PA - Panama 3
TW - Taiwan 3
EC - Ecuador 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
SI - Slovenia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.980
Salva come PNG Salva come JPEG
Città #
Chandler 339
Dublin 293
Singapore 231
Ashburn 225
Santa Clara 193
Hong Kong 170
Ann Arbor 146
Parma 103
Boardman 78
Dearborn 72
Izmir 72
Shanghai 70
Beijing 64
Munich 63
Nanjing 61
Princeton 57
Helsinki 54
Columbus 46
Wilmington 43
Bremen 40
Vienna 36
Turku 30
Hefei 29
Moscow 29
Abidjan 28
The Dalles 28
Chicago 27
New York 24
Kocaeli 21
Guangzhou 19
Council Bluffs 18
San Mateo 18
Los Angeles 17
Nanchang 17
Shenyang 17
Brussels 16
Falls Church 16
Hebei 16
Milan 15
Changsha 14
Bologna 13
Dallas 13
Jinan 13
London 13
Seattle 13
Brno 12
Jakarta 12
Jiaxing 12
Norwalk 12
São Paulo 12
Frankfurt am Main 9
Houston 9
Nuremberg 9
Des Moines 8
Fremont 8
Luxembourg 8
Florence 7
Istanbul 7
Rio de Janeiro 7
Dalmine 6
Hanoi 6
Modena 6
Sassari 6
Woodbridge 6
Aracaju 5
Bengaluru 5
Birmingham 5
Brasília 5
Charleroi 5
Fairfield 5
New Brunswick 5
Ningbo 5
Porto Alegre 5
Seoul 5
Tashkent 5
Ahmedabad 4
Angers 4
Brescia 4
Brooklyn 4
Cairo 4
Campinas 4
Chongqing 4
Curitiba 4
Dordrecht 4
Haikou 4
Ho Chi Minh City 4
Kunming 4
Kyiv 4
Ottawa 4
Pune 4
San Giuliano Milanese 4
Toronto 4
Verona 4
Washington 4
Zhengzhou 4
Amstelveen 3
Baghdad 3
Bandung 3
Bauru 3
Beitou 3
Totale 3.232
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 176
Nuovi composti antimicrobici 160
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 144
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 142
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 119
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 112
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 110
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 109
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 109
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 108
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 107
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 107
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 104
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 104
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 101
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 99
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 93
Antituberculosis agents: Beyond medicinal chemistry rules 93
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 89
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 87
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 86
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 85
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 83
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 83
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 83
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 83
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 82
Towards the sustainable discovery and development of new antibiotics 81
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 81
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 80
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 79
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 76
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 76
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 74
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 74
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 73
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 72
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 71
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 68
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 67
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 67
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 66
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 65
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 65
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 62
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 61
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 60
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 60
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 57
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 57
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 50
Indoleamides are active against drug-resistant mycobacterium tuberculosis 48
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 45
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 45
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 45
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 45
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 43
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 43
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 42
Spectinamides: A challenge, a proof, and a suggestion 41
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 41
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 41
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 40
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 40
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 37
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 35
Quorum sensing inhibitors (QSIs): a patent review (2019–2023) 6
Totale 5.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.064
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 3 5 8 10 6 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.751 64 90 144 95 151 221 109 69 155 163 195 295
2025/2026227 227 0 0 0 0 0 0 0 0 0 0 0
Totale 5.137